1
|
Prevodnik VK, Gašljević G. Cytokeratin and CD56 aberrant co-expression in diffuse large B-cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC. Cytopathology 2023; 34:165-168. [PMID: 36336889 PMCID: PMC10108145 DOI: 10.1111/cyt.13190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 10/20/2022] [Accepted: 10/24/2022] [Indexed: 11/09/2022]
Abstract
Aberrant expression of epithelial and neuroendocrine markers is rare in diffuse large B-cell lymphoma (DLBCL) and can lead to erroneous diagnosis with inappropriate treatment. This case report describes a case of DLBCL with a co-expression of cytokeratins and CD56 that was misdiagnosed as metastatic neuroendocrine carcinoma.
Collapse
Affiliation(s)
| | - Gorana Gašljević
- Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
| |
Collapse
|
2
|
Petronilho S, Gournay V, Tauziede-Espariat A, Pina H, Pecriaux A, Drieux F, Poullot E, Briere J, Lechapt E, Gaulard P. Lesson of the Month: ALK+ large B-cell lymphoma presenting as multiple bowel obstructing, cytokeratin-positive tumors. Histopathology 2022; 80:1128-1130. [PMID: 35238057 DOI: 10.1111/his.14635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 02/05/2022] [Accepted: 02/25/2022] [Indexed: 11/30/2022]
Affiliation(s)
- Sara Petronilho
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.,Portuguese Institute of Oncology, Porto, Portugal
| | - Viviane Gournay
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France
| | - Arnault Tauziede-Espariat
- Department of Neuropathology, GHU Paris - Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France.,Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR S1266, INSERM, IMA-BRAIN, Paris, France.,Université de Paris, Paris, France.,Medipath laboratory, Paris, France
| | - Héloïse Pina
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France
| | - Adrien Pecriaux
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France
| | - Fanny Drieux
- Department of Pathology, Henri Becquerel Center, Rouen, France
| | - Elsa Poullot
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.,IMRB, Inserm U955, Faculty of Medicine, University of Paris-Est Créteil, Créteil, France
| | - Josette Briere
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France
| | - Emmanuèle Lechapt
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.,IMRB, Inserm U955, Faculty of Medicine, University of Paris-Est Créteil, Créteil, France
| | - Phillippe Gaulard
- Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.,IMRB, Inserm U955, Faculty of Medicine, University of Paris-Est Créteil, Créteil, France
| |
Collapse
|
3
|
Maeshima AM, Taniguchi H, Hattori D, Sasaki H, Hori Y, Makita S, Iwaki N, Fukuhara S, Munakata W, Suzuki T, Izutsu K. CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: A histopathological study of 118 cases. Hum Pathol 2022; 124:14-23. [DOI: 10.1016/j.humpath.2022.03.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2022] [Revised: 02/27/2022] [Accepted: 03/12/2022] [Indexed: 11/28/2022]
|